The Canadian Hemophilia Society (CHS) is pleased to put out a special call for applications for two of its research programs for the 2021-2022 grant period: the CHS/Novo Nordisk Psychosocial Research Program and the CHS – Bayer – ADVANCE Canada Research Program.
Given that we received no applications for the November 16, 2020 deadline for the CHS/Novo Nordisk Psychosocial Research Program and the CHS – Bayer – ADVANCE Canada Research Program, we have decided to make a new last special call for these programs with a new deadline set for January 18, 2021. Details follow.
Ø CHS/Novo Nordisk Psychosocial Research Programme: applications from Social Workers, Nurses, or Physiotherapists with professional experience in a hemophilia treatment centre (or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders) or persons interested in the field of inherited bleeding disorders will be considered. Students in a PhD program in one of the allied health disciplines may also apply. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. Professional experience in a hemophilia treatment centre is desirable but not required.
Ø CHS/Bayer ADVANCE Canada Research Program: applicant must be a physician or Ph.D. with professional experience in a hemophilia treatment centre (HTC) or other comparable settings in which care has been provided to people with hemophilia and other inherited bleeding disorders. Professionals who have appointments in universities and who can dedicate time to research are encouraged to apply. The proposed research must have relevance to current practice in bleeding disorders care and may incorporate a broad spectrum of quantitative and qualitative research methods addressing professional practice with individuals, families, groups and communities, organizational issues, public health, and education.The research studies should aim to provide better data and tools to help the treaters assist patients in successful ageing.
CHS/NOVO NORDISK CANADA PSYCHOSOCIAL RESEARCH PROGRAMME
The CHS/Novo Nordisk Canada Psychosocial Research Program was created to engage hemophilia program professionals/graduate students from the allied health disciplines (ie. Nursing, Physiotherapy & Social Work) in research activities addressed to understanding the psychosocial impact of hemophilia and other inherited bleeding disorders and to improve the quality of life of persons and families whose lives are affected by these disorders.
The primary intent of this program is to offer one or two $20,000 research grants, to a maximum of $40,000 for one year.
Depending upon the number and quality of applications, funding for more than two research grant could be offered within the allotted total budget stated above.
The major portion of each grant would be to cover the research time for the successful candidate(s), including the time for research assistants. A small amount can be devoted to project expenses.
Collaboration with multidisciplinary care providers and/or between two or more hemophilia centres is accepted and encouraged. Collaboration efforts may include, for example, social work, physical therapy and genetics. It thus may be possible for a hemophilia centre team to jointly submit a cooperative research project. Additionally, inter-regional applications will be considered.
Applications and Deadline:
A letter of intent should be submitted to the Canadian Hemophilia Society by January 18, 2021. The letter, with a maximum of two pages, should identify the researcher, the organization and include a summary description of the intended area of research.
The CHS Peer Review Committee will invite a limited number of candidates to submit a more detailed proposal by February 1, 2021 in order to make a final selection. Grants will be offered for a one-year period to begin in April 2021.
More detailed information is available by accessing the CHS Web site at https://www.hemophilia.ca/the-chsnovo-nordisk-psychosocial-research-program/
The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program
The Canadian Hemophilia Society – Bayer ADVANCE Canada Research Program was created to engage Canadian hemophilia treaters in activities to identify and research key issues in the ageing hemophilia population.
The research program will support studies that aim to:
• Identify and provide insight into key issues associated with the ageing hemophilia population
• Identify how management of age-related co-morbidities should be adapted to those with hemophilia
• Create and deliver evidence-based information to health care practitioners (HCPs), the public and policy makers that will lead to improved care and QoL for older Canadians living with hemophilia
The primary intent of this program is to offer one or two $30,000 research grants, to a maximum of $60,000 for one year.
Applications and Deadline:
All completed application forms and support documents must arrive at the National Office of the Canadian Hemophilia Society on or before January 18, 2021.
Additional information, the eligibility criteria and conditions for the research program as well as the application form can be found on our website at this link: